Profile
Corporate information
Registration country
Registration country
Investment activity status
Active investor
Company type
A biotechnology company, develops medicines to treat cancer and fibrotic diseasesFunding
Funding rounds
Acquisition USD 225,000,000
USD 225,000,000 (20 Dec 2010) at USD 225,000,000 valuation.
Investor | Profile | Country | Notes | |
---|---|---|---|---|
Gilead Sciences Inc | A biopharmaceutical company that discovers, develops and commercializes therapeutics. | United States |
Investor | Profile | Country | Notes | |
---|---|---|---|---|
Duff Ackerman & Goodrich Ventures | A mid-stage venture capital partnership with a service-oriented mindset. | United States | ||
Healthcare Ventures LLC | Venture capital firm focused on life sciences companies in pre-clinical and early clinical stage. | United States | ||
Kleiner Perkins Caufield & Byers LLC | Venture capital firm. | United States | ||
Northgate Capital | United States |
Cap Table
Current and past shareholders
Investor | Contacts | Round | |
---|---|---|---|
Duff Ackerman & Goodrich Ventures A mid-stage venture capital partnership with a service-oriented mindset. |
+1 (415) 788-2755 |
N/A | |
Gilead Sciences Inc A biopharmaceutical company that discovers, develops and commercializes therapeutics. |
Acquisition | ||
Healthcare Ventures LLC Venture capital firm focused on life sciences companies in pre-clinical and early clinical stage. |
+1 (617) 252-4343 |
N/A | |
Kleiner Perkins Caufield & Byers LLC Venture capital firm. |
+1 (650) 233-2750 |
N/A | |
Northgate Capital |
N/A |